Read about the life of the Founder of MPNRF

MPN News | January 12, 2018

Obituary for Robert Rosen, Founder of the MPN Research Foundation

Read More

Celgene buys maker of Fedratinib

MPN News | January 9, 2018

Fedratinib may be approved for patients resistant to or intolerant of Jakafi

Read More

Two MPN experts discuss ASH 2017

MPN News | December 21, 2017

Return of old drugs, update to prognostic scoring system and more

Read More

Video updates from ASH 2017

MPN News | December 19, 2017

Four experts weigh in on the MPN updates

Read More

Ruxolitinib trial for Essential Thrombocythemia now enrolling patients

MPN News | November 13, 2017

Focus is on Hydroxyurea resistant/ intolerant ET

Read More

Patient Power webinar features PV patient discussing myMPN

MPN News | November 14, 2017

Dr. Srdan Verstovsek and MPNRF's Lindsey Whyte discuss new tool for patients

Read More

MPNRF Pursues Bold New Initiative: The Progression Marker Project

MPN News | 11/13/2017

MPNRF is launching a much needed initiative that could unlock answers about the rare blood cancer myeloproliferative neoplasms and identify new therapeutic targets.

Read More

NCCN develops patient-friendly MPN guidelines

MPN News | October 19, 2017

NCCN Guidelines for Patients are written in plain language and include patient-friendly tools.

Read More

New drug trial for Polycythemia Vera initiated by Roche

MPN News | October 18, 2017

Idasunutlin is in Phase 1 and enrolling patients now

Read More

A new study to explore the practicality and preliminary effects of two different non-pharmacologic strategies for MPN patient symptom burden

MPN News | September 28, 2017

Arizona State University, in partnership with University of Texas Health San Antonio Cancer Center, and the Mayo Clinic are seeking MPN patients to participate in an 8-week study that aims to explore the practicality and impact of different non-pharmacologic strategies (i.e., mobile app, education) to reduce fatigue in MPN patients.

Read More

MPNRF visits the FDA

MPN News | September 18, 2017

The FDA reached out to 3 MPN patient advocate groups including the MPN Research Foundation, had discussions about the concerns of MPN patients, and asked them to send representatives to an FDA Mini Symposium:

Read More

Announcing the MPN Interferon Initiative

MPN News | September 26, 2017

MPNRF goes after the JAK2 mutation and the mysteries of Interferon with new project

Read More
MPN News
Read More

September is Blood Cancer Awareness Month

MPN News | August 30, 2017

MPNRF has a few ways for you to take action

Read More

What does the approval of Kymriah mean for MPN?

MPN News | September 1, 2017

MPNRF asks immunotherapy expert Saar Gill about what we can expect

Read More

Check our News - Archive for older news.

Get updates on MPN patients and research breakthroughs.

What are the latest developments in MPN Research?